NASDAQ:OSUR OraSure Technologies (OSUR) Stock Forecast, Price & News $5.50 +0.01 (+0.18%) (As of 06/7/2023 ET) Add Compare Share Share Today's Range$5.45▼$5.5850-Day Range$4.88▼$7.3952-Week Range$2.62▼$7.82Volume503,600 shsAverage Volume593,948 shsMarket Capitalization$402.93 millionP/E Ratio14.10Dividend YieldN/APrice Target$5.00 ProfileProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainabilityProfileAnalyst RatingsChartCompetitorsEarningsFinancialsInsider TradesInstitutional OwnershipHeadlinesOptions ChainSEC FilingsShort InterestSocial MediaSustainability OraSure Technologies MarketRank™ ForecastAnalyst RatingN/A0.00 Rating ScoreUpside/Downside9.1% Downside$5.00 Price TargetShort InterestHealthy2.12% of Float Sold ShortDividend StrengthN/ASustainability-1.09Upright™ Environmental ScoreNews Sentiment0.94Based on 3 Articles This WeekInsider TradingN/AProj. Earnings GrowthDecreasingFrom $0.25 to ($0.26) Per ShareSee Full Details Hide Full Details Overall MarketRank™MarketRank is calculated as an average of available category scores, with extra weight given to analysis and valuation.1.41 out of 5 starsMedical Sector918th out of 981 stocksSurgical & Medical Instruments Industry91st out of 97 stocks 0.0 Analyst's Opinion Price Target Upside/DownsideAccording to analysts' consensus price target of $5.00, OraSure Technologies has a forecasted downside of 9.1% from its current price of $5.50.Amount of Analyst CoverageOraSure Technologies has received no research coverage in the past 90 days. Previous Next 3.0 Short Interest Percentage of Shares Shorted2.12% of the float of OraSure Technologies has been sold short.Short Interest Ratio / Days to CoverOraSure Technologies has a short interest ratio ("days to cover") of 2.4, which is generally considered an acceptable ratio of short interest to trading volume.Change versus previous monthShort interest in OraSure Technologies has recently increased by 15.62%, indicating that investor sentiment is decreasing significantly. Previous Next 0.0 Dividend Strength Dividend YieldOraSure Technologies does not currently pay a dividend.Dividend GrowthOraSure Technologies does not have a long track record of dividend growth. Previous Next 4.2 Sustainability and ESG Overall ESG (Environmental, Social, and Governance) ScoreOraSure Technologies has received a 61.52% net impact score from Upright. The largest positive contribution comes from its "Physical diseases" impact, which is mostly driven by its "DNA sequencers", "Genomics analysis tools", and "Respiratory tract infection tests" products. See details.Environmental SustainabilityThe Environmental Impact score for OraSure Technologies is -1.09. Previous Next 2.7 News and Social Media Coverage News SentimentOraSure Technologies has a news sentiment score of 0.94. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.51 average news sentiment score of Medical companies.News Coverage This WeekMarketBeat has tracked 3 news articles for OraSure Technologies this week, compared to 1 article on an average week.Search InterestOnly 4 people have searched for OSUR on MarketBeat in the last 30 days. This is a decrease of -69% compared to the previous 30 days.MarketBeat FollowsOnly 3 people have added OraSure Technologies to their MarketBeat watchlist in the last 30 days. This is a decrease of -40% compared to the previous 30 days. Previous Next 1.7 Company Ownership Insider Buying vs. Insider SellingIn the past three months, OraSure Technologies insiders have not sold or bought any company stock.Percentage Held by InsidersOnly 2.20% of the stock of OraSure Technologies is held by insiders.Percentage Held by Institutions85.62% of the stock of OraSure Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company. Previous Next 1.3 Earnings and Valuation Earnings GrowthEarnings for OraSure Technologies are expected to decrease in the coming year, from $0.25 to ($0.26) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of OraSure Technologies is 14.10, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 136.18.Price to Earnings Ratio vs. SectorThe P/E ratio of OraSure Technologies is 14.10, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 103.62.Price to Book Value per Share RatioOraSure Technologies has a P/B Ratio of 1.10. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities. Previous Next See Top Rated MarketRank™ Stocks Here About OraSure Technologies (NASDAQ:OSUR) StockOraSure Technologies, Inc. engages in the development, manufacture, and distribution of point of care diagnostic tests and molecular collection devices designed to detect or diagnose critical medical conditions. It operates through the OSUR and DNAG segments. The OSUR segment offer oral fluid diagnostic products and specimen collection devices. The DNAG segment produces specimen collection kits that are used to collect, stabilize, transport, and store samples of genetic material for molecular testing in the consumer genetic, clinical genetic, academic research, pharmacogenomics, personalized medicine, microbiome, and animal genetics markets. The company was founded by Michael J. Gausling in May 2000 in and is headquartered in Bethlehem, PA.Read More Receive OSUR Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OraSure Technologies and its competitors with MarketBeat's FREE daily newsletter. Email Address OSUR Stock News HeadlinesJune 2, 2023 | msn.comOraSure Technologies' CFO Makes Bold Insider Purchase, Reigniting Investor ConfidenceMay 16, 2023 | finance.yahoo.comTime To Worry? Analysts Just Downgraded Their OraSure Technologies, Inc. (NASDAQ:OSUR) OutlookJune 7, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 13, 2023 | americanbankingnews.comOraSure Technologies (NASDAQ:OSUR) Sees Unusually-High Trading VolumeMay 13, 2023 | americanbankingnews.comOraSure Technologies (NASDAQ:OSUR) Upgraded by StockNews.com to "Buy"May 12, 2023 | msn.comRecap: OraSure Technologies Q1 EarningsMay 12, 2023 | finance.yahoo.comCan Mixed Fundamentals Have A Negative Impact on OraSure Technologies, Inc. (NASDAQ:OSUR) Current Share Price Momentum?May 11, 2023 | finance.yahoo.comQ1 2023 OraSure Technologies Inc Earnings CallJune 7, 2023 | Behind the Markets (Ad)Laser breakthrough could send stock soaring 2,467%Laser breakthrough could send stock soaring 2,476% Whenever the military develops a breakthrough technology, timely investors could see groundbreaking returns. General Dynamics returned 8,990%... Boeing soared 4,238%... L3Harris shot up 1,628%...May 10, 2023 | finance.yahoo.comOraSure Technologies (OSUR) Q1 Earnings and Revenues Beat EstimatesMay 10, 2023 | finance.yahoo.comOraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core GrowthMay 10, 2023 | finance.yahoo.comOraSure Reports 1Q23 Record Revenue of $155.0 Million; Announces New Collaborations as Company Increasingly Focuses on Core GrowthMay 6, 2023 | benzinga.comOraSure Technologies Stock (NASDAQ:OSUR), DividendsMay 3, 2023 | finance.yahoo.com2023 First Quarter Earnings Conference Call Wednesday, May 10, 2023, 5:00 p.m. ETApril 21, 2023 | finance.yahoo.comIs OraSure Technologies (OSUR) Outperforming Other Medical Stocks This Year?April 13, 2023 | americanbankingnews.comOraSure Technologies (NASDAQ:OSUR) Stock Price Down 3.6%April 12, 2023 | americanbankingnews.comOraSure Technologies (NASDAQ:OSUR) Reaches New 52-Week High at $7.06April 5, 2023 | finance.yahoo.comOraSure (OSUR) Stock Jumps 9.3%: Will It Continue to Soar?March 29, 2023 | finance.yahoo.comWe're Hopeful That OraSure Technologies (NASDAQ:OSUR) Will Use Its Cash WiselyMarch 20, 2023 | finance.yahoo.com3 Low-Beta Stocks to Buy to Combat the Volatile MarketMarch 8, 2023 | finance.yahoo.comOraSure Technologies, Inc. (NASDAQ:OSUR) is a favorite amongst institutional investors who own 79%February 23, 2023 | finance.yahoo.comSurging Earnings Estimates Signal Upside for OraSure (OSUR) StockFebruary 16, 2023 | finance.yahoo.comOraSure Technologies, Inc. (NASDAQ:OSUR) Q4 2022 Earnings Call TranscriptFebruary 16, 2023 | finance.yahoo.comOraSure Technologies Full Year 2022 Earnings: Beats ExpectationsFebruary 15, 2023 | finance.yahoo.comWhy OraSure Technologies Stock Is Jumping TodayFebruary 15, 2023 | prnewswire.comThinking about buying stock in OraSure Technologies, Argo Blockchain, Pagaya Technologies, BioSig Technologies, or Roblox?February 14, 2023 | msn.comOraSure Technologies Non-GAAP EPS of $0.36 beats by $0.32, revenue of $123.08M beats by $26.2MSee More Headlines OSUR Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart OSUR Company Calendar Last Earnings2/14/2023Today6/07/2023Next Earnings (Estimated)8/08/2023Fiscal Year End12/31/2023Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeNASDAQ Industry Surgical & medical instruments Sub-IndustryHealth Care Supplies SectorMedical Current SymbolNASDAQ:OSUR CUSIP68554V10 CIK1116463 Webwww.orasure.com Phone(610) 882-1820Fax610-882-1830Employees785Year FoundedN/APrice Target and Rating Average Stock Price Forecast$5.00 High Stock Price Forecast$5.00 Low Stock Price Forecast$5.00 Forecasted Upside/Downside-9.1%Consensus RatingN/A Rating Score (0-4)0.00 Research Coverage0 Analysts Profitability EPS (Most Recent Fiscal Year)$0.39 Trailing P/E Ratio14.10 Forward P/E Ratio22.00 P/E GrowthN/ANet Income$-17,930,000.00 Net Margins6.16% Pretax Margin5.59% Return on Equity12.66% Return on Assets10.35% Debt Debt-to-Equity RatioN/A Current Ratio6.23 Quick Ratio4.83 Sales & Book Value Annual Sales$387.48 million Price / Sales1.04 Cash FlowN/A Price / Cash FlowN/A Book Value$5.01 per share Price / Book1.10Miscellaneous Outstanding Shares73,260,000Free Float71,650,000Market Cap$402.93 million OptionableOptionable Beta0.09 Key ExecutivesCarrie Eglinton MannerPresident, Chief Executive Officer & DirectorZachary WertSenior Vice President-Global OperationsKenneth McGrathChief Financial OfficerRafal IwasiowVice President, Science-Innovation & TechnologyMichele AnthonyChief Accounting Officer, SVP & ControllerKey CompetitorsAnika TherapeuticsNASDAQ:ANIKCerusNASDAQ:CERSUtah Medical ProductsNASDAQ:UTMDAtrionNASDAQ:ATRIAngioDynamicsNASDAQ:ANGOView All CompetitorsInsiders & InstitutionsAmeriprise Financial Inc.Bought 64,182 shares on 5/22/2023Ownership: 0.623%JPMorgan Chase & Co.Bought 25,307 shares on 5/18/2023Ownership: 0.176%New York State Common Retirement FundSold 15,994 shares on 5/18/2023Ownership: 0.047%Thrivent Financial for LutheransSold 2,523 shares on 5/17/2023Ownership: 0.155%Graham Capital Management L.P.Bought 67,521 shares on 5/16/2023Ownership: 0.149%View All Insider TransactionsView All Institutional Transactions OSUR Stock - Frequently Asked Questions What is OraSure Technologies' stock price forecast for 2023? 0 brokers have issued 12 month price objectives for OraSure Technologies' shares. Their OSUR share price forecasts range from $5.00 to $5.00. On average, they expect the company's share price to reach $5.00 in the next year. This suggests that the stock has a possible downside of 9.1%. View analysts price targets for OSUR or view top-rated stocks among Wall Street analysts. How have OSUR shares performed in 2023? OraSure Technologies' stock was trading at $4.82 at the beginning of the year. Since then, OSUR stock has increased by 14.1% and is now trading at $5.50. View the best growth stocks for 2023 here. When is OraSure Technologies' next earnings date? The company is scheduled to release its next quarterly earnings announcement on Tuesday, August 8th 2023. View our OSUR earnings forecast. How were OraSure Technologies' earnings last quarter? OraSure Technologies, Inc. (NASDAQ:OSUR) issued its earnings results on Tuesday, February, 14th. The medical instruments supplier reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.01 by $0.21. The medical instruments supplier had revenue of $123.08 million for the quarter, compared to analyst estimates of $96.88 million. OraSure Technologies had a trailing twelve-month return on equity of 12.66% and a net margin of 6.16%. The company's quarterly revenue was up 93.6% compared to the same quarter last year. During the same quarter last year, the business posted ($0.14) EPS. What ETFs hold OraSure Technologies' stock? ETFs with the largest weight of OraSure Technologies (NASDAQ:OSUR) stock in their portfolio include Inspire Fidelis Multi Factor ETF (FDLS), ETFMG Treatments Testing and Advancements ETF (GERM), Invesco Nasdaq Future Gen 200 ETF (QQQS), Invesco S&P SmallCap Health Care ETF (PSCH), SPDR S&P Health Care Equipment ETF (XHE), Syntax Stratified SmallCap ETF (SSLY), Principal Healthcare Innovators ETF (BTEC) and What guidance has OraSure Technologies issued on next quarter's earnings? OraSure Technologies updated its second quarter 2023 earnings guidance on Friday, May, 12th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $62.00 million-$67.00 million, compared to the consensus revenue estimate of $96.67 million. What is Stephen Tang's approval rating as OraSure Technologies' CEO? 2 employees have rated OraSure Technologies Chief Executive Officer Stephen Tang on Glassdoor.com. Stephen Tang has an approval rating of 100% among the company's employees. This puts Stephen Tang in the top 10% of approval ratings compared to other CEOs of publicly-traded companies. What other stocks do shareholders of OraSure Technologies own? Based on aggregate information from My MarketBeat watchlists, some companies that other OraSure Technologies investors own include Merit Medical Systems (MMSI), Citigroup (C), Energy Transfer (ET), XOMA (XOMA), Overstock.com (OSTK), Ford Motor (F), Pfizer (PFE), Abbott Laboratories (ABT), Advanced Micro Devices (AMD) and Activision Blizzard (ATVI). What is OraSure Technologies' stock symbol? OraSure Technologies trades on the NASDAQ under the ticker symbol "OSUR." Who are OraSure Technologies' major shareholders? OraSure Technologies' stock is owned by many different institutional and retail investors. Top institutional investors include BlackRock Inc. (17.62%), State Street Corp (4.11%), Dimensional Fund Advisors LP (3.64%), American Capital Management Inc. (3.03%), Renaissance Technologies LLC (2.07%) and Geode Capital Management LLC (1.92%). Insiders that own company stock include Michael Celano, Nancy J Gagliano and Ronny B Lancaster. View institutional ownership trends. How do I buy shares of OraSure Technologies? Shares of OSUR stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here. What is OraSure Technologies' stock price today? One share of OSUR stock can currently be purchased for approximately $5.50. How much money does OraSure Technologies make? OraSure Technologies (NASDAQ:OSUR) has a market capitalization of $402.93 million and generates $387.48 million in revenue each year. The medical instruments supplier earns $-17,930,000.00 in net income (profit) each year or $0.39 on an earnings per share basis. How many employees does OraSure Technologies have? The company employs 785 workers across the globe. How can I contact OraSure Technologies? OraSure Technologies' mailing address is 220 EAST FIRST STREET, BETHLEHEM PA, 18015. The official website for the company is www.orasure.com. The medical instruments supplier can be reached via phone at (610) 882-1820, via email at investorinfo@orasure.com, or via fax at 610-882-1830. This page (NASDAQ:OSUR) was last updated on 6/7/2023 by MarketBeat.com Staff Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OraSure Technologies, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.